Cargando…
Supply-side and demand-side policies for biosimilars: an overview in 10 European member states
Objective: This study aimed to provide an overview of biosimilar policies in 10 EU MSs. Methods: Ten EU MS pharmaceutical markets (Belgium, France, Germany, Greece, Hungary, Italy, Poland, Spain, Sweden, and the UK) were selected. A comprehensive literature review was performed to identify supply-si...
Autores principales: | Rémuzat, Cécile, Kapuśniak, Anna, Caban, Aleksandra, Ionescu, Dan, Radière, Guerric, Mendoza, Cyril, Toumi, Mondher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Routledge
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508392/ https://www.ncbi.nlm.nih.gov/pubmed/28740617 http://dx.doi.org/10.1080/20016689.2017.1307315 |
Ejemplares similares
-
Key drivers for market penetration of biosimilars in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2017) -
Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017) -
New drug regulations in France: what are the impacts on market access? Part 1 – Overview of new drug regulations in France
por: Rémuzat, Cécile, et al.
Publicado: (2013) -
Value added medicines: what value repurposed medicines might bring to society?
por: Toumi, Mondher, et al.
Publicado: (2016) -
Overview of external reference pricing systems in Europe
por: Rémuzat, Cécile, et al.
Publicado: (2015)